Turning Breakthrough Discoveries
into Medicines
At 1STBIO, we strive to transform the lives of patients by relentlessly discovering and developing novel therapeutics to address areas of significant unmet need. Inspired by science and innovation, we dedicate our expertise and experience in drug development to bring forward a pioneering change.
At 1STBIO, we strive to transform the lives of patients by relentlessly discovering and developing novel therapeutics to address areas of significant unmet need. Inspired by science and innovation, we dedicate our expertise and experience in drug development to bring forward a pioneering change.
Key Focus areas
We are developing a portfolio of drug candidates in the field of Neurodegenerative Disease, Immuno-Oncology and Rare Disease as well as developing Genomic-based target discovery platform for neurodegenerative target and biomarker discovery.
Meet the Team
1STBIO was founded by experienced veterans in the life science industry with an aim to assemble a team with scientific, clinical, and business expertise. Since its inception, seasoned professionals in their respective fields have joined together with an unwavering focus on discovering and developing therapeutics to improve patients’ lives.
Latest News
퍼스트바이오, 세계적 암 연구기관 ‘모핏’과 면역항암제 개발 협력
February 11, 2025
Moffitt Cancer Center and 1ST Biotherapeutics Announce Strategic Alliance To Transform Cancer Treatment
February 11, 2025
리가켐바이오와 ADC 공동연구로 새로운 항암 치료 가능성 탐색
December 13, 2024
2024년 제2회 임시주주총회 소집공고
November 12, 2024
Where We’re Located
1ST Biotherapeutics, Inc.
338, Gwanggyojungang-ro, Gwanggyowoominewv, Suji-gu, Yongin-si, Gyeonggi-do, South Korea
Suite C509-510, C803, C806-809